Trevena, Inc.
COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME
Last updated:
Abstract:
The present embodiments are directed, in part, to compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof for modulating the activity of S.sub.1P.sub.1 receptor and methods of using the same.
Status:
Application
Type:
Utility
Filling date:
12 Jun 2018
Issue date:
24 Jun 2021